Reach Us +44-1753390542
Salvage Liver Transplantation for HCC: An Old Story without Consensus? | OMICS International | Abstract
ISSN: 2161-0991

Journal of Transplantation Technologies & Research
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)


Salvage Liver Transplantation for HCC: An Old Story without Consensus?

Gonzalo Sapisochin1* and Ramón Charco2

1Department of HBP Surgery & Transplantation, Hospital Universitario Vall d´Hebron, Barcelona, Spain

2Universidad Autónoma de Barcelona, Barcelona, Spain

*Corresponding Author:
Gonzalo Sapisochin
Department of HBP Surgery & Transplantation
Hospital Universitario Vall d´Hebron
Barcelona, Spain
E-mail: [email protected]

Received Date: July 27, 2011; Accepted Date: October 31, 2011; Published Date: November 04, 2011

Citation: Sapisochin G, Charco R (2011) Salvage Liver Transplantation for HCC: An Old Story without Consensus? J Transplant Technol Res 1: 106e. doi: 10.4172/2161-0991.1000106e

Copyright: © 2011 Sapisochin G, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Hepatocellular carcinoma (HCC), the most common liver tumor is a leading cause of mortality, accounting for more than 1 million deaths annually. Most HCC are diagnosed in association with liver cirrhosis, with the main risk factors being hepatitis B and C and alcohol abuse. In the past, HCC was diagnosed at advanced stages; no treatment could be applied and the prognosis was poor. Fortunately, as a result of screening programs in high-risk populations, patients with HCC are now diagnosed at an early stage, and up to 30% can be considered for a curative treatment. These curative treatments include liver resection (LR), liver transplantation (LT) and percutaneous ablation [1]. LT is the most effective treatment for patients with HCC since it removes the tumor and surrounding cirrhotic tissue, the main risk factor for the development of new tumors. Following the Milan criteria (single tumors = 5 cm or 3 tumors all of them = 3 cm), up to 75% 4-year survival has been described with a low recurrence rate (<10%) constituting the most extended criteria for LT for HCC [2]. Some groups have developed expanded criteria for LT for HCC such as the UCSF criteria and the up-to-seven criteria, with acceptable results.

Recommended Conferences

4th Annual Summit on Surgery and Transplantation

Singapore, Singapore

International Congress on Gastroenterology and Liver Transplant

Auckland, New Zealand
Share This Page